doi: 10.1016/0026-0495(89)90260-6.
Diphosphonates inhibit human osteoblast secretion and proliferation
Affiliations
- PMID: 2521525
- DOI: 10.1016/0026-0495(89)90260-6
Item in Clipboard
Diphosphonates inhibit human osteoblast secretion and proliferation
Metabolism.
1989 Feb.
Abstract
In view of the beneficial effect of diphosphonates in Paget's disease and their suppressive effect on alkaline phosphatase, the action of three diphosphonates (aminohydroxypropylidene diphosphonate [APD], clodronate, and didronel) on cultured human osteoblasts in vitro was investigated. All three inhibited basal and 1,25(OH)2 cholecalciferol-stimulated alkaline phosphatase secretion and [3H]thymidine uptake by osteoblasts. It is concluded that diphosphonates consistently inhibit human osteoblasts through a direct action in addition to their known effect on inhibiting bone resorption and that these actions together may form the basis of their beneficial effect in vivo in patients with Paget's disease.
Similar articles
-
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.Cancer Res. 2000 Nov 1;60(21):6001-7. Cancer Res. 2000. PMID: 11085520
-
Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.J Endocrinol Invest. 2002 Jun;25(6):539-46. doi: 10.1007/BF03345497. J Endocrinol Invest. 2002. PMID: 12109626
-
Inorganic polyphosphate in human osteoblast-like cells.J Bone Miner Res. 1998 May;13(5):803-12. doi: 10.1359/jbmr.1998.13.5.803. J Bone Miner Res. 1998. PMID: 9610744
-
Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.Drugs. 1991 Feb;41(2):289-318. doi: 10.2165/00003495-199141020-00009. Drugs. 1991. PMID: 1709854 Review.
-
Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats.Am J Pathol. 1977 Oct;89(1):137-52. Am J Pathol. 1977. PMID: 143891 Free PMC article. Review.
Cited by
-
Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.Mol Pharm. 2011 Aug 1;8(4):1016-24. doi: 10.1021/mp100374n. Epub 2011 Jan 21. Mol Pharm. 2011. PMID: 21186792 Free PMC article.
-
Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects.Clin Rheumatol. 2005 Sep;24(5):527-34. doi: 10.1007/s10067-005-1100-2. Epub 2005 Aug 10. Clin Rheumatol. 2005. PMID: 16091841
-
The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts.J Mater Sci Mater Med. 2002 Oct;13(10):923-31. doi: 10.1023/a:1019892109411. J Mater Sci Mater Med. 2002. PMID: 15348185
-
Changes in bone mineral density in patients with Paget's disease treated with risedronate.Ann Rheum Dis. 1997 Jul;56(7):405-9. doi: 10.1136/ard.56.7.405. Ann Rheum Dis. 1997. PMID: 9486001 Free PMC article.
-
Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.Oral Maxillofac Surg. 2022 Jun;26(2):321-332. doi: 10.1007/s10006-021-00982-8. Epub 2021 Aug 15. Oral Maxillofac Surg. 2022. PMID: 34392434 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
